• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次发作后复发的风险及对驾驶的影响:早期癫痫和单次发作的多中心研究的进一步分析。

Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures.

机构信息

Department of Biostatistics, University of Liverpool.

出版信息

BMJ. 2010 Dec 7;341:c6477. doi: 10.1136/bmj.c6477.

DOI:10.1136/bmj.c6477
PMID:21147743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998675/
Abstract

OBJECTIVE

To determine for how long after a first unprovoked seizure a driver must be seizure-free before the risk of recurrence in the next 12 months falls below 20%, enabling them to regain their driving licence.

DESIGN

Randomised controlled trial: Multicentre study of early Epilepsy and Single Seizures (MESS).

SETTING

UK hospital outpatient clinics from 1 January 1993 to 31 December 2000.

PARTICIPANTS

People entered MESS if they had had one or more unprovoked seizures and both the participant and the clinician were uncertain about the need to start antiepileptic drug treatment. The subset of people used for this analysis comprised participants aged at least 16 years with a single unprovoked seizure.

MAIN OUTCOME MEASURE

Risk of seizure recurrence in the 12 months after a seizure-free period of 6, 12, 18, or 24 months from the date of the first (index) seizure. Regression modelling was used to investigate how antiepileptic treatment and several clinical factors influence the risk of seizure recurrence.

RESULTS

At six months after the index seizure the risk of recurrence in the next 12 months for those who start antiepileptic drugs was significantly below 20% (unadjusted risk 14%, 95% confidence interval 10% to 18%). For patients who did not start treatment the risk estimate was less than 20% but the upper limit of the confidence interval was greater than 20% (18%, 13% to 23%). Multivariable analyses identified subgroups with a significantly greater than 20% risk of seizure recurrence in the 12 months after a six month seizure-free period, such as those with a remote symptomatic seizure with abnormal electroencephalogram results.

CONCLUSION

After a single unprovoked seizure this reanalysis of MESS provides estimates of seizure recurrence risks that will inform policy and guidance about regaining an ordinary driving licence. Further guidance is needed as to how such data should be utilised; in particular, whether a population approach should be taken with a focus on the unadjusted results or whether attempts should be made to individualise risk. Guidance is also required as to whether the focus should be on risk estimates only or on the confidence interval as well. If the focus is on the estimate only our unadjusted estimates suggest that treated and untreated patients are eligible to drive after being seizure-free for six months. If the focus is also on confidence intervals, direction is needed as to whether a conservative or liberal approach should be taken.

TRIAL REGISTRATION

Current Controlled Trials ISRCTN98767960.

摘要

目的

确定首次无诱因癫痫发作后,驾驶员需要多长时间无癫痫发作,才能使下一个 12 个月内的复发风险低于 20%,从而恢复驾驶执照。

设计

随机对照试验:早期癫痫和单次发作的多中心研究(MESS)。

地点

英国医院门诊,1993 年 1 月 1 日至 2000 年 12 月 31 日。

参与者

MESS 纳入的参与者如果有一次或多次无诱因癫痫发作,且参与者和临床医生都不确定是否需要开始抗癫痫药物治疗。本分析所用的亚组包括年龄至少 16 岁、有一次无诱因癫痫发作的参与者。

主要观察指标

首次(索引)癫痫发作后 6、12、18 或 24 个月无癫痫发作期间,12 个月内癫痫发作的复发风险。回归模型用于研究抗癫痫治疗和几种临床因素如何影响癫痫发作的复发风险。

结果

在索引癫痫发作后 6 个月,开始抗癫痫药物治疗者下一个 12 个月内复发的风险显著低于 20%(未调整风险 14%,95%置信区间 10%至 18%)。未开始治疗者的风险估计值低于 20%,但置信区间上限大于 20%(18%,13%至 23%)。多变量分析确定了在 6 个月无癫痫发作后 12 个月内癫痫复发风险显著大于 20%的亚组,例如伴有异常脑电图结果的远因症状性癫痫发作。

结论

在单次无诱因癫痫发作后,对 MESS 的重新分析提供了有关恢复普通驾驶执照的癫痫复发风险的估计值,这将为政策和指导提供信息。需要进一步指导如何利用这些数据;特别是,是否应该采用以人群为基础的方法,侧重于未经调整的结果,还是应该尝试对风险进行个体化评估。还需要指导是否应该只关注风险估计值,还是也应该关注置信区间。如果重点是估计值,我们未经调整的估计值表明,在无癫痫发作 6 个月后,治疗和未治疗的患者有资格驾驶。如果重点也在置信区间上,则需要指明是采取保守还是宽松的方法。

试验注册

当前对照试验 ISRCTN98767960。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/4787712/68e9ace692b6/bonl767186.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/4787712/68e9ace692b6/bonl767186.f1_default.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f66c/4787712/68e9ace692b6/bonl767186.f1_default.jpg

相似文献

1
Risk of recurrence after a first seizure and implications for driving: further analysis of the Multicentre study of early Epilepsy and Single Seizures.首次发作后复发的风险及对驾驶的影响:早期癫痫和单次发作的多中心研究的进一步分析。
BMJ. 2010 Dec 7;341:c6477. doi: 10.1136/bmj.c6477.
2
Risk of a seizure recurrence after a breakthrough seizure and the implications for driving: further analysis of the standard versus new antiepileptic drugs (SANAD) randomised controlled trial.突破性癫痫发作后癫痫复发的风险及其对驾驶的影响:标准抗癫痫药物与新型抗癫痫药物(SANAD)随机对照试验的进一步分析
BMJ Open. 2017 Jul 10;7(7):e015868. doi: 10.1136/bmjopen-2017-015868.
3
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
4
Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.首次无诱因发作的癫痫患者,即刻给予抗癫痫药物治疗与安慰剂、延迟治疗或不治疗的比较。
Cochrane Database Syst Rev. 2021 May 4;5(5):CD007144. doi: 10.1002/14651858.CD007144.pub3.
5
Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.对于首次无诱因发作,立即给予抗癫痫药物治疗与给予安慰剂、延迟治疗或不治疗的比较。
Cochrane Database Syst Rev. 2016 May 6;2016(5):CD007144. doi: 10.1002/14651858.CD007144.pub2.
6
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.卡马西平与苯巴比妥单药治疗癫痫:个体参与者数据回顾。
Cochrane Database Syst Rev. 2018 Oct 24;10(10):CD001904. doi: 10.1002/14651858.CD001904.pub4.
7
Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review.丙戊酸钠与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD001769. doi: 10.1002/14651858.CD001769.pub4.
8
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.托吡酯与卡马西平单药治疗癫痫:个体参与者数据回顾。
Cochrane Database Syst Rev. 2019 Jun 24;6(6):CD012065. doi: 10.1002/14651858.CD012065.pub3.
9
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.奥卡西平与苯妥英单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2018 Oct 23;10(10):CD003615. doi: 10.1002/14651858.CD003615.pub4.
10
Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review.抗癫痫药物停药后发作复发及其对驾驶的影响:来自 MRC 抗癫痫药物停药研究的进一步结果和系统评价。
J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1328-33. doi: 10.1136/jnnp.2010.222885. Epub 2011 Jan 13.

引用本文的文献

1
Does the Timing of Electroencephalogram Recording After a First Unprovoked Seizure Influence Its Ability to Predict Additional Seizures?首次无诱因发作后脑电图记录的时间会影响其预测再次发作的能力吗?
Eur J Neurol. 2025 Sep;32(9):e70288. doi: 10.1111/ene.70288.
2
Association of the Timing and Type of Acute Symptomatic Seizures With Poststroke Epilepsy and Mortality.急性症状性癫痫发作的时间和类型与卒中后癫痫及死亡率的关联
Stroke. 2025 Jul;56(7):1748-1757. doi: 10.1161/STROKEAHA.124.050045. Epub 2025 Apr 24.
3
Epilepsy in rural South Africa: Patient experiences and healthcare challenges.

本文引用的文献

1
Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial.单次发作和早期癫痫后癫痫复发风险的预测:MESS试验的进一步结果
Lancet Neurol. 2006 Apr;5(4):317-22. doi: 10.1016/S1474-4422(06)70383-0.
2
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.早期癫痫和单次发作的即刻与延迟抗癫痫药物治疗:一项随机对照试验
Lancet. 2005;365(9476):2007-13. doi: 10.1016/S0140-6736(05)66694-9.
3
Epilepsy and driving in Belgium: proposals and justification.
南非农村的癫痫:患者的体验和医疗保健挑战。
Epilepsia Open. 2024 Aug;9(4):1565-1574. doi: 10.1002/epi4.12999. Epub 2024 Jun 17.
4
Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABAR Antibodies: Implications for Return to Driving.抗 NMDAR、LGI1、CASPR2 和 GABAR 抗体自身免疫性脑炎导致癫痫复发的风险:对恢复驾驶的影响。
Neurol Neuroimmunol Neuroinflamm. 2024 Jul;11(4):e200225. doi: 10.1212/NXI.0000000000200225. Epub 2024 Jun 4.
5
Implications for driving based on the risk of seizures after ischaemic stroke.基于缺血性脑卒中后癫痫发作风险的驾驶影响。
J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):833-837. doi: 10.1136/jnnp-2024-333505.
6
Predictive Power of Interictal Epileptiform Discharges in Fitness-to-Drive Evaluation.发作间期痫样放电对驾驶适性评估的预测能力。
Neurology. 2023 Aug 29;101(9):e866-e878. doi: 10.1212/WNL.0000000000207531. Epub 2023 Jul 6.
7
Antiseizure Medication Withdrawal Practice Patterns: A Survey Among Members of the American Academy of Neurology and EpiCARE.抗癫痫药物撤药实践模式:美国神经病学学会和癫痫照护研究组成员的一项调查
Neurol Clin Pract. 2023 Feb;13(1):e200109. doi: 10.1212/CPJ.0000000000200109. Epub 2023 Jan 13.
8
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
9
Protocol for an observational cohort study investigating biomarkers predicting seizure recurrence following a first unprovoked seizure in adults.一项观察性队列研究方案,旨在研究生物标志物预测成人首次无诱因癫痫发作后癫痫复发的情况。
BMJ Open. 2022 Dec 5;12(12):e065390. doi: 10.1136/bmjopen-2022-065390.
10
Risk of seizure recurrence in people with single seizures and early epilepsy - Model development and external validation.单次发作及早期癫痫患者癫痫复发风险——模型构建与外部验证
Seizure. 2022 Jan;94:26-32. doi: 10.1016/j.seizure.2021.11.007. Epub 2021 Nov 23.
比利时的癫痫与驾驶:建议及理由
Acta Neurol Belg. 2004 Jun;104(2):68-79.
4
The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme.间变性星形细胞瘤或多形性胶质母细胞瘤患者的生存条件概率。
Surg Neurol. 2003 Nov;60(5):402-6; discussion 406. doi: 10.1016/s0090-3019(03)00322-7.
5
Individual state driving restrictions for people with epilepsy in the US.美国针对癫痫患者的各州驾驶限制。
Neurology. 2001 Nov 27;57(10):1780-5. doi: 10.1212/wnl.57.10.1780.
6
The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data.原发性恶性脑肿瘤患者生存的条件概率:监测、流行病学和最终结果(SEER)数据。
Cancer. 1999 Jan 15;85(2):485-91.
7
Epilepsy and driving: an international perspective. Joint Commission on Drivers' Licensing of the International Bureau for Epilepsy and the International League Against Epilepsy.癫痫与驾驶:国际视角。国际癫痫局和国际抗癫痫联盟驾驶员执照联合委员会。
Epilepsia. 1994 May-Jun;35(3):675-84. doi: 10.1111/j.1528-1157.1994.tb02491.x.
8
National General Practice Study of Epilepsy: recurrence after a first seizure.
Lancet. 1990 Nov 24;336(8726):1271-4. doi: 10.1016/0140-6736(90)92960-p.
9
Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Collaborative Group for the Study of Epilepsy.新转诊患者癫痫的预后:单药治疗对癫痫长期病程影响的多中心前瞻性研究。癫痫研究协作组
Epilepsia. 1992 Jan-Feb;33(1):45-51. doi: 10.1111/j.1528-1157.1992.tb02281.x.